Chronic Low Back Pain Clinical Trial
Official title:
A Prospective Controlled Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
This is a prospective observational cohort multinational clinical study. There are no biomarkers to help predict in which patients acute low back pain (LBP) will transform into chronic low back pain (CLBP). Human variability and different common comorbidities complicate the picture and make stratification of patients into correct subgroups difficult. However, drugs act by targeting specific molecular pathways and are therefore efficient only in a subgroup of patients sharing common molecular pathology and common genetics. Both CLBP and disc degeneration are known to be heritable. Little investigation has taken place for genetic variants in CLBP. The main aim of this trial is to identify "omics biomarkers" associated with the transition from acute (single episode of low back pain) to persistent/chronic LBP (pain lasting more than 12 weeks).
Investigators will link and relate clinical data to a multiple "omics" analysis in patients
developing persistent chronic symptoms (defined as pain that persists 3 months or more),
after an episode of acute LBP. The development of persistent chronic pain will be assessed
at 3 months after the acute episode.
"OMIC" biomarkers investigated will be genetics, epigenetics, glycomics and activomic.
Genetics through genome wide association studies (GWAS) has already obtained important
results in pain research; however concerning low back pain, there is not yet suitable
genotype-phenotype correlations helpful to stratify patients.
Epigenetic regulation is a universal tool that higher organisms use to adapt to changes in
the environment. While environmental factors, such as diet influence enzymatic processes
only while they are directly present, their prolonged effects can be achieved through the
cell memory of epigenetic marks. Various elements of the membrane signal transduction system
were reported to be regulated by epigenetic mechanisms.
Glycomics is an emerging field that has recently been identified as a priority for the next
decade by the US National Academies of Science. Many common complex diseases will be
associated with specific changes in glycan structures. In addition, common genetic
polymorphisms influencing glycosylation and consequent differences in glycome composition
could be important diagnostic and prognostic markers. The first studies reporting protein
glycosylation in large human population samples have been recently published by partners in
the consortium. Reliable identification of valid associations between specific
glyco-phenotypes and predisposition for the development or progression of a specific disease
requires analysis of thousands of patients.
Activomics: combines data about enzymatic activity of numerous numerous post-translational
modification proteins in an integrated model which provides dynamic characterization of the
current state of an organism. In this project information about numerous proteases, kinases,
phosphatases and glycosidases will be collected and used to complement the existing
phenotype information.
"Omics" data will be compared stratifying population according to pain characteristics, pain
intensity, response to treatment and duration of pain. In a subgroup of patients, "omics"
data will be compared stratifying population according to pain pathophysiology: discogenic
pain, spinal stenosis, facet joint pain, sacroiliac joint pain, low back pain with radicular
pain (radicular pain not predominant) and widespread low back pain.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
| Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
| Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
| Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
| Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
| Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
| Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
| Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
| Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
| Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
| Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
| Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
| Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
| Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
| Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
| Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
| Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
| Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
| Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |